MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
GoodRx Holdings Interest Expense 2011-2026 | GDRX
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense GoodRx Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.66 M | -4.01 M | - | - | 22 K | -2.97 M | -7 K | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 22 K | -4.01 M | -1.92 M |
Quarterly Interest Expense GoodRx Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 694 K | - | -2.66 M | - | - | -2.2 M | - | -1.81 M | - | - | - | - | - | - | - | - | - | -1 K | 16 K | 5 K | - | 4 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 694 K | -2.66 M | -744 K |
Interest Expense of other stocks in the Health information services industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
-147 K | - | 0.29 % | $ 206 M |  USA |
 |
Cerner Corporation
CERN
|
43.5 M | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
12.5 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
32 M | - | - | $ 2.94 B | USA |
 |
Change Healthcare
CHNG
|
234 M | - | - | $ 9.03 B | USA |
 |
iCAD
ICAD
|
-49 K | - | - | $ 102 M | USA |
 |
Evolent Health
EVH
|
15.6 M | $ 2.53 | 8.58 % | $ 237 M | USA |
 |
Akerna Corp.
KERN
|
-221 K | - | - | $ 161 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
13.2 M | - | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
-265 K | - | -0.58 % | $ 51.7 M | USA |
 |
NextGen Healthcare
NXGN
|
3.52 M | - | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
-13.8 M | - | - | $ 3.37 B | USA |
 |
OptimizeRx Corporation
OPRX
|
1.45 M | $ 5.93 | -3.26 % | $ 102 M | USA |
 |
HealthEquity
HQY
|
12.1 M | $ 79.91 | 2.5 % | $ 6.88 B | USA |
 |
Premier
PINC
|
102 M | - | - | $ 2.33 B | USA |
 |
Schrödinger
SDGR
|
16.4 M | $ 11.45 | 0.7 % | $ 841 M | USA |
 |
Phreesia
PHR
|
2.95 M | $ 8.56 | 6.2 % | $ 511 M | USA |
 |
Teladoc Health
TDOC
|
10.4 M | $ 5.22 | 2.35 % | $ 920 M | USA |
 |
10x Genomics
TXG
|
33 K | $ 23.58 | 1.33 % | $ 2.76 B | USA |
 |
Signify Health
SGFY
|
20.6 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
-2 K | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
-2.65 M | - | -46.64 % | $ 10.4 M | USA |
 |
SCWorx Corp.
WORX
|
279 K | $ 1.06 | -30.72 % | $ 7.71 M | USA |
 |
American Well Corporation
AMWL
|
5.17 M | $ 5.55 | 6.12 % | $ 89.1 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
1.06 M | - | - | $ 255 M | USA |
 |
HealthStream
HSTM
|
-318 K | $ 20.37 | 2.46 % | $ 619 M | USA |
 |
Omnicell
OMCL
|
-270 K | $ 35.01 | 1.77 % | $ 1.61 B | USA |
 |
Progyny
PGNY
|
1.87 M | $ 16.98 | 4.17 % | $ 1.46 B | USA |
 |
So-Young International
SY
|
12 M | $ 2.69 | 4.26 % | $ 214 M |  China |
 |
Veeva Systems
VEEV
|
278 M | $ 158.45 | 4.66 % | $ 25.9 B | USA |
 |
Zhongchao
ZCMD
|
34 K | $ 2.01 | 1.01 % | $ 6.87 M | China |